Zdrowie i gospodarka · 28/09/2015

FDA to Hold Public Meeting on Labeling for Lower-Dose Estrogen Products for Vulvar and Vaginal Atrophy Symptoms

The FDA is hosting a public meeting to discuss labeling for lower-dose estrogen products, which are used to treat moderate to severe symptoms of vulvar and vaginal atrophy in menopausal women, and to gather input from experts on the current labeling and its applicability to these products.